Ors explains how the biotech, which has experience carrying out clinical trials in oncology, is developing a vaccine that is unique to its peers'.
IMV advancing its potential immune-boosting coronavirus vaccine
Quick facts: IMV Inc
Price: 3.47 USD
Market Cap: $232.81 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE